Tam-Peli meets primary endpoint for relapsed small-cell lung cancer in phase III trial
Tam-Peli meets primary endpoint for relapsed small-cell lung cancer in phase III trial The Clinical Trial Vanguard
Онкология
🎗️Лента новостей
Онкология
8 знаменитостей, которые победили онкологию
8 знаменитостей, которые победили онкологию Здоровье Mail
Онкология
8 знаменитостей, которые победили онкологию
8 знаменитостей, которые победили онкологию Здоровье Mail
🎗️
Онкология
AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial
AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial FirstWord Pharma
Онкология
В России изобрели лекарство от рака: «Большая фарма» показывает, кто на нем разбогатеет - business-gazeta.ru
В России изобрели лекарство от рака: «Большая фарма» показывает, кто на нем разбогатеет business-gazeta.ru
Онкология
В России изобрели лекарство от рака: «Большая фарма» показывает, кто на нем разбогатеет
В России изобрели лекарство от рака: «Большая фарма» показывает, кто на нем разбогатеет БИЗНЕС Online
Онкология
Phase III TAISHAN-302 trial shows Tam-Peli significantly improves survival in relapsed small-cell lung cancer
Phase III TAISHAN-302 trial shows Tam-Peli significantly improves survival in relapsed small-cell lung cancer EurekAlert!
Онкология
Antibody-Drug Combination Falls Short in First-Line PD-L1-High Metastatic Lung Cancer Trial
Antibody-Drug Combination Falls Short in First-Line PD-L1-High Metastatic Lung Cancer Trial Bioengineer.org
🎗️
Онкология
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences Peking Union Medical CollegeのJie Wang教授は述べた。
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences Peking Union Medical CollegeのJie Wang教授は述べた。 EurekAlert!
Онкология
Phase III ARTEMIS-008 trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer
Phase III ARTEMIS-008 trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer EurekAlert!
Онкология
Студент Ханойского медицинского университета и его неожиданное путешествие в область онкологии.
Студент Ханойского медицинского университета и его неожиданное путешествие в область онкологии. Vietnam.vn
Онкология
Exercise Could Help Cancer Patients on Immunotherapy, But Nobody Is Telling Them How
Exercise Could Help Cancer Patients on Immunotherapy, But Nobody Is Telling Them How Bioengineer.org
🎗️
Онкология
Trial supports MRI surveillance over preventive brain radiation in small-cell lung cancer
Results from the international phase 3 SWOG S1827 MAVERICK trial show that brain MRI surveillance alone improved cognitive failure-free survival compared with MRI surveillance plus prophylactic cranial irradiation (PCI) in patients with small-cell lung cancer (SCLC). The findings support MRI surveillance alone as the…
Онкология
Ivonescimab significantly improves overall survival versus pembrolizumab in advanced lung cancer
Ivonescimab significantly prolonged overall survival compared with pembrolizumab as first-line treatment for patients with PD-L1-positive advanced non-small cell lung cancer (NSCLC), according to a prespecified interim analysis of the phase 3 HARMONi-2 trial presented today at the IASLC 2026 World Conference on Lung…